Article Sidebar
Published:
Jan 11, 2025Keywords:
Article Details
While African Health Sciences has been freely accessible online there have been questions on whether it is Open Access or not. We wish to clearly state that indeed African Health Sciences is Open Access. There are key issues regarding Open Access needing clarification for avoidance of doubt:
- 1. Henceforth, papers in African Health Sciences will be published under the CC BY (Creative Commons Attribution License) 4.0 International. See details on https://creativecomons.org/)
- 2. The copyright owners or the authors grant the 3rd party (perpetually and in advance) the right to disseminate, reproduce, or use the research papers in part or in full, format/medium as long as:
- No substantive errors are introduced in the process
- Attribution of authorship and correct citation details are given
- The referencing details are not changed.
Should the papers be reproduced in part, this must be clearly stated.
- 3. The papers will be freely and universally accessible online in an easily readable format such as XML in at least one widely recognized open access repository such as PUBMED CENTRAL.
B. ABRIDGED LICENCE AGREEMENT BETWEEN AUTHORS AND African Health Sciences
I submitted my manuscript to African Health Sciences and would like to affirm that:
1.0 I am authorized by my co-authors to enter into these arrangements.
2.0 I guarantee, on behalf of self and co-authors:
- That the paper is original, and has not been published in any other peer-reviewed journal; nor is it under consideration by other journal (s). It does not infringe existing copyright or any other person’s rights
- That we are/I am the sole author(s) of the paper and with authority to enter into this agreement. My granting rights to African Health Sciences is not in breach of any other obligation
- That the paper contains nothing unlawful, or libelous. Nor anything that would constitute a breach of contract, confidence or commitment given to secrecy, if published
- That I/we have taken care to ensure the integrity of the article.
3.0 I and all co-authors, agree that the paper, if accepted for publication, shall be licensed under the Creative Commons Attribution License 4.0. (see https://creativecommons.org/)
Main Article Content
Recent updates on molecular epidemiology of hepatitis C virus in Gujranwala, Pakistan
Abstract
Background: Hepatitis C infection (HCV) remains a leading cause of liver cirrhosis, posing a critical health threat worldwide.
Objective: This research aimed to provide a contemporary overview of HCV infection and its genotypic distribution in Gujranwala, Punjab, Pakistan. Additionally, it sought to explore the interrelation between HCV genotypes and associated risk factors among individuals infected with HCV.
Method: To examine the prevalence of antibodies against HCV, blood samples were collected from 1004 patients and tested using an immunochromatographic test (ICT). Positive ICT samples were subsequently confirmed through a chemiluminescence technique and then subjected to amplification and genotyping.
Results: The study revealed that females (54.68%) were more affected by HCV than males (45.32%). Notably, the highest incidence of HCV infection (27%) was observed in the 50-59 age group. Among HCV RNA-positive patients, genotype 3a predominated, accounting for 71.81% of cases. High rate of untypable genotypes was also detected (20.82%), along with mixed (3.29%), 1a (2.09%), 1b (0.79%), 2b (0.70%), and 3b (0.50%).
Conclusion: The study highlights the prevalence of genotype 3a as the most common HCV genotype in the sampled population. This information is crucial for informing public health interventions and further research in the field of HCV infection.
Keywords: Hepatitis C Virus; molecular epidemiology; genotypes.
